StonvexLoading…
StonvexStonvexStonvexCore line items from ALVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $586.32M | $489.68M | $91.43M | $83.03M |
Operating Income | $78.21M | $69.64M | $-354.86M | $-346.44M |
Net Income | $27.92M | $-231.86M | $-551.73M | $-513.58M |
EPS (Diluted) | $0.10 | $-0.87 | $-2.43 | $-2.60 |
Total Assets | $1.49B | $1.22B | $950.09M | $828.44M |
Total Liabilities | $1.77B | $1.63B | $1.88B | $1.39B |
Cash & Equivalents | $172.36M | $51.43M | $11.16M | $66.43M |
Free Cash Flow OCF − CapEx | $-114.67M | $-290.50M | $-345.42M | $-350.27M |
Shares Outstanding | 312.02M | 301.81M | 266.82M | 252.16M |